[Form 4] Accenture plc Insider Trading Activity

Rhea-AI Filing Summary

Accenture plc officer Katherine Lee Clifford reported receiving a grant of 32 Class A ordinary shares in the form of restricted share units. The grant occurred on 11/14/2025 at a price of $0 per share, reflecting anti-dilution adjustments to previously granted RSU awards following Accenture plc's payment of a cash dividend.

After this transaction, Clifford beneficially owns 4,919 Class A ordinary shares directly and 27 shares indirectly through an immediate family member. The filing is made on behalf of Clifford by an attorney-in-fact and reflects routine equity compensation adjustments tied to dividend payments rather than an open-market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clifford Katherine Lee

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Leadership & HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	11/14/2025		A		32(1)	A	$0	4,919	D
Class A ordinary shares								27	I	Held by an Immediate Family Member

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Katherine Lee Clifford	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Accenture (ACN) disclose about Katherine Lee Clifford in this Form 4?

The Form 4 reports that officer Katherine Lee Clifford, Chief Leadership & HR Officer of Accenture plc, received 32 Class A ordinary shares in the form of restricted share units on 11/14/2025, with a reported price of $0 per share.

Why did Katherine Lee Clifford receive 32 RSUs from Accenture (ACN)?

The 32 restricted share units were granted under the anti-dilution provisions of previously granted RSU awards, specifically to reflect Accenture plc's payment of a cash dividend, adjusting prior awards rather than creating a new incentive program.

How many Accenture (ACN) shares does Katherine Lee Clifford own after this transaction?

Following the reported grant, Katherine Lee Clifford beneficially owns 4,919 Class A ordinary shares directly and 27 shares indirectly that are held by an immediate family member.

Was there any cash paid for the 32 RSUs reported by Accenture (ACN)?

No cash was paid for this grant; the filing shows a price of $0 per share for the 32 Class A ordinary shares issued as restricted share units.

What is Katherine Lee Clifford’s role at Accenture (ACN)?

Katherine Lee Clifford is reported as an officer of Accenture plc, serving as the Chief Leadership & HR Officer, according to the relationship section of the filing.

Does this Accenture (ACN) Form 4 involve derivative securities like options or warrants?

The filing includes a Table II heading for derivative securities, but no specific derivative securities are listed with transaction details in the provided content.